Selected article for: "early testing promote and immunosorbent assay"
Author: Wu, Xiaobing; Guan, Yang; Ye, Jianbin; Fu, Hanlin; Zhang, Chunlai; Lan, Lina; Wu, Fengxin; Tang, Fen; Wang, Feng; Cai, Yumao; Yu, Weiye; Feng, Tiejian
Title: Association between syphilis seroprevalence and age among blood donors in Southern China: an observational study from 2014 to 2017
  • Document date: 2019_11_2
    • ID: ubnv0fdw_23
    Snippet: The findings confirm the high prevalence of syphilis among older adults, and suggest the need to increase awareness among healthcare providers and deliver more targeted prevention interventions for older adults to promote early testing. ï‚„ The testing process in this study, using enzyme-linked immunosorbent assay (ELISA) as a screening test and then using Treponema pallidum particle agglutination assay (TPPA) and toluidine red unheated serum tes.....
    Document: The findings confirm the high prevalence of syphilis among older adults, and suggest the need to increase awareness among healthcare providers and deliver more targeted prevention interventions for older adults to promote early testing. ï‚„ The testing process in this study, using enzyme-linked immunosorbent assay (ELISA) as a screening test and then using Treponema pallidum particle agglutination assay (TPPA) and toluidine red unheated serum test (TRUST) to confirm the serostatus, increased the accuracy of syphilis seroprevalence.

    Search related documents:
    Co phrase search for related documents
    • early testing and healthcare provider: 1
    • early testing and high prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • early testing and immunosorbent assay: 1
    • early testing and pallidum particle: 1, 2
    • early testing and pallidum particle agglutination: 1, 2
    • early testing and pallidum particle agglutination assay: 1, 2
    • early testing and prevention intervention: 1
    • early testing and screening test: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • early testing and serostatus confirm: 1
    • early testing and serum test: 1, 2, 3, 4
    • early testing promote and high prevalence: 1, 2, 3, 4, 5
    • early testing promote and pallidum particle: 1, 2
    • early testing promote and pallidum particle agglutination: 1, 2
    • early testing promote and pallidum particle agglutination assay: 1, 2
    • early testing promote and screening test: 1
    • early testing promote and serostatus confirm: 1
    • early testing promote and serum test: 1, 2
    • ELISA immunosorbent assay and enzyme link: 1
    • ELISA immunosorbent assay and high prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9